TMCnet News

OncLive® Presents State of the Science Summit™ on Genitourinary Malignancies
[July 20, 2017]

OncLive® Presents State of the Science Summit™ on Genitourinary Malignancies


OncLive®, a leading digital provider of resources and information to oncology professionals, announces the latest State of the Science Summit™: Updates in Genitourinary Malignancies, which will be held at 5 p.m. Tuesday, Sept. 19, 2017, at Yale's West Campus in Orange (News - Alert), Connecticut. The program will be chaired by Daniel Petrylak, M.D., Disease Aligned Research team leader of the Prostate and Urologic Cancers Program at Smilow Cancer Hospital and professor of medical oncology and urology at Yale Cancer Center, and will feature distinguished speakers from the field of oncology.

This educational event will discuss some of the most pressing issues faced by oncologists and other medical experts when dealing with genitourinary malignancies. The summit will discuss critical topics such as bone targeting, treatment of castration-resistant metastatic prostate cancer, kidney cancer and new clinical trials. During a 45-minute networking reception, the summit will offer attendees food and drinks. Speakers from Yale Cancer Center and Yale School of Medicine include:

  • Hari A. Deshpande, M.D., associate professor of medicine (medical oncology)
  • Michael Hurwitz, M.D., Ph.D., assistant professor of medicine (medical oncology)
  • Joseph W. Kim, M.D., assistant professor of medicine (medical oncology)
  • Harriet Kuger, M.D., professor of medicine (medical oncology)
  • Preston C. Sprenkle, M.D., assistant professor of urology
  • James B. Yu, M.D., M.H.S., associate professor of therapeutic radiology



OncLive® established the State of the Science Summits to assemble academic and community-based physicians and health care professionals across key disciplines from medical and surgical oncology. Each summit convenes for a short meeting designed to educate health care professionals on the clinical benefits associated with new science driving new thinking in cancer management. Attendees will not only improve their knowledge of novel treatment approaches but also leave the summit with the confidence and intent to apply state-of-the-art treatment strategies to care for their patients. Each summit is dedicated to the latest research in one of the following therapeutic areas: breast cancer, lung cancer, genitourinary and prostate cancer, hematology, head and neck cancer, gastrointestinal cancer, ovarian cancer, or melanoma.

For more information and to register, visit www.onclive.com/meetings/soss or contact Allison Cooper at [email protected].


About OncLive®

A digital platform of resources for practicing oncologists, OncLive.com offers oncology professionals information they can use to help provide the best patient care. OncLive® is the official website for Michael J. Hennessy Associates' Oncology Specialty Group, which publishes OncologyLive®, Oncology Nursing News®, Oncology Business Management™ and more. Michael J. Hennessy Associates Inc. is a full-service health care communications company offering education, research and medical media, including curetoday.com and CURE® magazine, the largest U.S. consumer publication focused entirely on cancer. Combining science and humanity to make cancer understandable, CURE® reaches patients, cancer centers and advocacy groups.


[ Back To TMCnet.com's Homepage ]